January 2, 2013

Mylan announced that its subsidiary, Mylan Pharmaceuticals, has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug applications for rizatriptan benzoate orally disintegrating tablets and rizatriptan benzoate tablets, generic versions of Merck's Maxalt MLT Tablets and Maxalt Tablets.

January 2, 2013

The U.S. Food and Drug Administration on Monday approved Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients taking antiretroviral therapy, a combination of medicines used to treat HIV infection.

January 2, 2013

While the "fiscal cliff" bill heads off the most severe tax implications for most Americans, the 25.8 million Americans with diabetes may find this bill a bitter pill to swallow, suggested the National Community Pharmacists Association in a press release.

January 2, 2013

To help ensure the quality of popular food ingredients increasingly being incorporated into products sold in the United States and worldwide, standards for omega 3-rich krill oil and natural, low-calorie stevia sweeteners are among the latest proposed revisions to the Food Chemicals Codex, the U.S. Pharmacopeial Convention that publishes the codex announced Wednesday.

January 2, 2013

A St. John's University College of Pharmacy and Health Sciences Doctor of Pharmacy Candidate last week picked up on a petition to recognize pharmacists as health care providers and filed the petition on the Obama Administration's "We the People" web site, according to a report published online by The Pharmacopedia.

January 2, 2013

Rite Aid announced a special series of 50th Anniversary customer appreciation savings as the culmination of RA50, its 50th anniversary celebration, which began last September.

January 2, 2013

Wall Street on Wednesday celebrated the "fiscal cliff" compromise as stocks across the board were trading up by some 200 basis points. As of noon, the Dow was up 1.7% and Nasdaq 2.3%.

January 2, 2013

Ulta Beauty is helping beauty mavens ring in the New Year with resolutions designed to create healthy skin all year long.

January 2, 2013

Walgreens on Wednesday announced that all Walgreens locations will host a "Night at the W" to celebrate the retail pharmacy operator's involvement in the People's Choice Awards.

January 2, 2013

To meet growing consumer demand for healthier choices, Whole Foods Market is introducing Engine 2 Plant-Strong products, a new line of plant-based, minimally processed snacks, breakfast items and pantry staples.

January 2, 2013

Zak Designs is looking to expand its environmental commitment by launching a new line of dinnerware, serveware and kitchen prep items, all made from recycled melamine.

December 28, 2012

Half of the primary care work-site health centers managed by Walgreens Employer Solutions Group have received AAAHC accreditation as patient-centered medical homes, with plans to have all of the company’s employer-based primary care centers accredited in the first half of 2013.

The news speaks to the quality of care delivered at Walgreens work sites, and as employers increasingly look for ways to curb healthcare costs and boost employee productivity, one can expect to see greater growth of such facilities going forward.

December 28, 2012

Boldface Group — a celebrity beauty licensing company that focuses on entertainment and designer opportunities in the market, including the "Khroma Beauty by Kourtney, Kim and Khloe Kardashian" brand — closed on $2 million in financing, the company has announced.

December 28, 2012

The incidence of influenza continued on an upward trajectory heading into the Christmas holiday, the Centers for Disease Control and Prevention reported.

December 28, 2012

Emergent BioSolutions announced that it has signed a license agreement with VaxInnate Corporation under which Emergent acquired the exclusive right to manufacture and sell VaxInnate’s pandemic influenza vaccine candidate in the United States.

December 28, 2012

Mylan on Friday announced that its subsidiary, Mylan Pharmaceuticals, has received final approval from the U.S. Food and Drug Administration for its phenytoin chewable tablets USP in the 50 mg strength.

December 28, 2012

Teva Pharmaceuticals has received approval of their new drug application for topotecan hydrochloride injection, a treatment for small cell lung cancer, according to Food and Drug Administration records.

December 28, 2012

Hillshire Brands will introduce new products in the frozen breakfast category over the next few years in an effort for the company to become the most innovative meat-centric food company throughout North America.

December 28, 2012

A federal judge in Washington has dismissed a suit against the FDA brought up by Mylan for withholding approval for the company to sell a generic version of Novartis AG’s heart pill, Diovan.

December 28, 2012

Mylan on Friday announced that its partner Famy Care has received final approval from the Food and Drug Administration for its abbreviated new drug application for levonorgestrel and ethinyl estradiol Tablets USP in the 0.15mg/0.03mg strength.

December 28, 2012

The filing seeks to establish a fund to compensate individuals and families affected by a nationwide meningitis outbreak.

December 28, 2012

Solidifying Perrigo’s leadership position in topical foam-based generic prescription pharmaceuticals, the company announced it has signed a definitive merger agreement and completed the acquisition of Cobrek Pharmaceuticals.

December 28, 2012

Publix Super Markets on Thursday announced it has signed a lease for a second store in the Charlotte, N.C. area.

December 28, 2012

Rite Aid last week posted a third quarter profit of $61.9 million, marking the first time Rite Aid has been back in the quarterly black since June 2007. The quarterly report beat analyst expectations as the generic wave and retention of Express Scripts customers helped drive better-than-expected adjusted EBIDTA.

It's certainly a timely Christmas gift that Rite Aid delivered to those shareholders who believed in the Pennsylvania pharmacy operation when it's stock hovered around $1 per share; in the week following the third quarter conference call Rite Aid's stock price was up some 40%.